Monday 27 August 2018

Veterinary Reference Laboratories (VRL) Analysis Market is anticipated to attain around USD 5.13 Billion By 2025: Grand view Research, Inc.






The global veterinary Reference Laboratories (VRL) market is expected to reach USD 5.13 billion by 2025, according to a new report by Grand View Research, Inc. Increase in incidence of zoonotic diseases is a key driving factor for market growth. Increase in adoption of integrated diagnostic systems coupled with information ecosystems for veterinary diagnostics is anticipated to fuel development.
Rise in demand for advanced diagnostic tests and growing awareness amongst consumers are some of the factors expected to boostdemandover the coming years. Moreover, companies are investing in R&D for the advancement of test kits for cost-effective diagnosis & monitoring of animal health, which is expected to boost growth. Some of the advancements in this market include efficient information management systems used in animal diagnostic applications, vaccine banks, and mobile apps for continuous monitoring. High focus toward innovation in veterinary health is anticipated to fuel the demand for reference labs. For instance, Innovative Medicines Initiative (IMI) is a public-private partnership that supports pharmaceutical innovations in Europe.
In addition, MediLabSecure, a laboratory network project was established, which aims to identify emerging viruses& pathogens in 19 countries in the Mediterranean regions and 57 labs were involved. Furthermore, increase in the number of government initiatives to promote veterinary diagnostics products is presumed to drive the overall growth. 
Full Research Report On Veterinary Reference Laboratories (VRL) Market Analysis:


Further Key Findings From the Study Suggest:
·         The clinical chemistry analyzers segment held the dominant share of the market as of 2016 owing to growing demand for veterinary diagnostics products
·         Increase ininstances of contamination in pet foods that causesevere illnesses and deaths amongst animalsis expected to boost the demand for toxicology testing services
·         Production animals accounted for largest revenue share in 2016 owing to their highest consumption rate
·         The market was dominated by North America and is expected to retain its position throughout the forecast period
·         Presence of prominent industry players, advanced healthcare infrastructure, and high healthcare expenditure are some of the factors responsible for growth
·         Companies offering reference laboratories are focusing on the development of cost-effective diagnostic solutions for animal health
·         IDEXX Laboratories, Inc. held a dominant share owing to its presence across the globe and a wide product portfolio of advanced diagnostic tests
·         Strategies such as regional expansion, new product developments, merger & acquisitions, and research collaborations are anticipated to propel growth
·         For instance, inJanuary 2017, Mars, Inc. announced the agreement for acquiring VCA Inc. in a probe to capture higher share

View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/healthcare
Grand View Research has segmented VRL market on the basis of the technology, application, animal type,and region:
VRL Technology Outlook (Revenue, USD Million, 2014 - 2025)
·         Clinical Chemistry
·         Hematology
·         Immunodiagnostics
o    ELISA
o    Lateral Flow Rapid Tests
o    Others
·         Molecular Diagnostics
o    PCR
o    Microarrays
o    Others
·         Others
VRL Application Outlook (Revenue, USD Million, 2014 - 2025)
·         Clinical Pa


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/


Lactoferrin Analysis Market is anticipated to attain around USD 167.9 Million By 2025: Grand view Research, Inc.





U.S. Lactoferrin Market revenue by function, 2014 - 2025 (Tons)

The global lactoferrin market is expected to reach USD 167.9 million by 2025, according to a new report by Grand View Research, Inc. Increasing demand for infant formula has been a major factor driving market growth. Utilization of lactoferrin has increased owing to the rising health concerns among consumers.
Lactoferrin is derived from the transferrin family and is a multifunctional protein. Transferrins are glycoproteins and are known to have the ability to control the free iron content in the human body, and bind them together. The transferrin family derivative is present in extensive quantities in various parts of the human body including, tears, nasal secretions, milk, and saliva.
The multifunctional protein helps to separate the free iron in the human body and also remove any content which promotes bacterial activity. The transferring family derivative helps to inhibit the bacterial growth by binding the lipopolysaccharides with bacterial walls and thus forming peroxides. Owing to this ability of the multifunctional protein, it is widely used in the healthcare sector for curing and preventing bacterial infections & diseases. The antibacterial function of lactoferrin is projected to show a high growth over the next eight years. The antibacterial function segment had a market share of 20.4% in 2016.
Infant formula application segment is expected to have a steady growth rate over the next eight years with an estimated CAGR of 8.1%. The multifunctional protein is the key component of human milk required for infants as they help in iron absorption and its transportation. Cow’s milk contains the multifunctional protein in minute quantities of 0.1 mg/mL, whereas infants require it in the quantities of 2-3 mg/mL. Commercially produced infant formula with lactoferrin content has high iron absorption, antibacterial, and antioxidation properties. This factor is projected to propel the infant formula segment growth over the next eight years.
Full Research Report On Lactoferrin Market Analysis:
http://www.grandviewresearch.com/industry-analysis/lactoferrin-market

Further key findings from the report suggest:
·         The global lactoferrin demand was 255.0 tons in 2016 and is expected to grow at a CAGR of 8.1% from 2017 to 2025
·         Iron absorption emerged as the largest function segment in 2016 and is estimated to be worth 151.9 tons by 2025
·         Intestinal flora protection is anticipated to be the fastest growing function segment over the next eight years and is estimated to grow at a CAGR of 8.7%
·         The global lactoferrin demand in food & beverages application was valued at USD 19.7 million in 2016 and is anticipated to witness steady growth over the next eight years
·         Industry participants include Metagenics, Pharming Group N.V., Vitalus Nutrition Inc., Ingredia SA., MP Biomedicals, Glanbia Nutritionals, Farbest Brands, Fonterra Co-Operative Group Ltd., and ProHealth

Grand View Research has segmented the global lactoferrin market on the basis of function, application, and region:
Lactoferrin Function Outlook (Revenue, USD Million; Volume Tons, 2014 - 2025)
·         Iron absorption
·          Anti-inflammatory
·          Intestinal flora protection
·          Antibacterial
·          Immune cell stimulation
·          Antioxidant
Lactoferrin Application Outlook (Revenue, USD Million; Volume Tons, 2014 - 2025)
·         Food & beverages
·         Infant formula
·         Sports & functional food
·         Animal feed
·         Pharmaceuticals
·         Personal care products
Lactoferrin Regional Outlook (Revenue, USD Million; Volume Tons, 2014 - 2025)
·         North America
o    U.S.
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    China
o    Japan
·         Central & South America
·         Middle East & Africa


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/

Hemodialysis And Peritoneal Analysis Market is anticipated to attain around USD 108.5 Billion by 2025: Grand view Research, Inc.


Hemodialysis And Peritoneal Analysis Market is anticipated to attain around USD 108.5 Billion by 2025: Grand view Research, Inc. 



U.S. Hemodialysis And Peritoneal Dialysis Market, by product, 2014-2025 (USD Million)

The global hemodialysis and peritoneal dialysis market is expected to reach USD 108.5 billion by 2025, according to a new report by Grand View Research, Inc. Home-based dialysis treatment is anticipated to witness lucrative growth over the forecast period. Factors supporting this trend include; increasing development of small and automated products capable of providing treatment at home, rising number of individuals requiring daily procedures, growing number of individuals aptly trained to perform self-treatment, and initiatives by market participants toward raising education and training for home dialysis performance.
This industry is highly competitive with a few players holding relatively high proportion of the market share. However, the dominance of each player is in a separate region thereby limiting direct competition. For instance, Baxter generates higher revenue in Europe whereas Fresenius Medical Care AG & Co. KGaA gains higher revenue in the U.S. This scenario is anticipated to change over the forecast period owing to increasing globalization, and efforts by companies to expand their revenues and profits.
Full Research Report On Hemodialysis And Peritoneal Dialysis Market Analysis:
http://www.grandviewresearch.com/industry-analysis/hemodialysis-peritoneal-dialysis-market

Further key findings from the study suggest:
·         Hemodialysis dominates the industry with over 80.0% of the market share. These processes are performed in centers as well as in home settings primarily for adults. This enhanced applicability and benefits in comparison to peritoneal dialysis are expected to promote growth.
·         Presence of treatment centers and skilled personnel in abundance to carry out procedures is expected to drive the growth for these services. Factors responsible for higher market share of services may be classified into rising number of centers, development of training courses for home-based patients, and rising number of patients requiring dialysis treatment.
·         Home-based procedures are anticipated to witness the fastest growth over the forecast period. Development of small & portable systems along with with rising healthcare literacy amongst patients are vital impact rendering drivers.
·         Regionally, Asia Pacific is predicted to contribute higher revenue share over the forecast period. Improving healthcare infrastructure, rising disposable income, and growing incidence of conditions such as diabetes within the region are expected to support growth.
·         Players highlighted in the study include Fresenius Medical Care AG & Co. KGaA, NIPRO Medical Corporation, B. Braun Avitum AG, Baxter, and DaVita Inc. These companies are aggressively working toward purchasing dialysis centers or establishing new centers to cater to the rising demand.
View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global hemodialysis and peritoneal dialysis market on the basis of type, product, end-use, and region:
Global Hemodialysis And Peritoneal Dialysis Type Outlook (Revenue, USD Million, 2014-2025)
·         Hemodialysis
o    Conventional
o    Short Daily
o    Nocturnal
·         Peritoneal Dialysis
o    CAPD
o    APD
Global Hemodialysis And Peritoneal Dialysis Product Outlook (Revenue, USD Million, 2014-2025)
·         Device
o    Machine
o    Dialyzers
o    Water Treatment System
o    Others
·         Consumables
o    Bloodline
o    Concentrates
o    Catheters
o    Others
·         Services
Global Hemodialysis And Peritoneal Dialysis End-use Outlook (Revenue, USD Million, 2014-2025)
·         Home-based
·         Hospital-based
Hemodialysis And Peritoneal Dialysis Regional Outlook (Revenue, USD Million, 2014-2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Mexico
·         Middle East and Africa (MEA)
o    South Africa

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/